BR112015029521A2 - alquilação com um sulfonato de alquil fluoroalquila - Google Patents

alquilação com um sulfonato de alquil fluoroalquila

Info

Publication number
BR112015029521A2
BR112015029521A2 BR112015029521A BR112015029521A BR112015029521A2 BR 112015029521 A2 BR112015029521 A2 BR 112015029521A2 BR 112015029521 A BR112015029521 A BR 112015029521A BR 112015029521 A BR112015029521 A BR 112015029521A BR 112015029521 A2 BR112015029521 A2 BR 112015029521A2
Authority
BR
Brazil
Prior art keywords
preparation
alkylation
sulfonate
alkyl
reagents
Prior art date
Application number
BR112015029521A
Other languages
English (en)
Portuguese (pt)
Inventor
Veitch Gemma
Acemoglu Murat
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of BR112015029521A2 publication Critical patent/BR112015029521A2/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
    • C07D498/18—Bridged systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/436—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a six-membered ring having oxygen as a ring hetero atom, e.g. rapamycin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C303/00—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides
    • C07C303/26—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides of esters of sulfonic acids
    • C07C303/28—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides of esters of sulfonic acids by reaction of hydroxy compounds with sulfonic acids or derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02—Silicon compounds
    • C07F7/08—Compounds having one or more C—Si linkages
    • C07F7/18—Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
    • C07F7/1804—Compounds having Si-O-C linkages

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Transplantation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
BR112015029521A 2013-06-20 2014-06-18 alquilação com um sulfonato de alquil fluoroalquila BR112015029521A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201361837224P 2013-06-20 2013-06-20
PCT/IB2014/062375 WO2014203185A1 (en) 2013-06-20 2014-06-18 Alkylation with an alkyl fluoroalkyl sulfonate

Publications (1)

Publication Number Publication Date
BR112015029521A2 true BR112015029521A2 (pt) 2017-07-25

Family

ID=51014598

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112015029521A BR112015029521A2 (pt) 2013-06-20 2014-06-18 alquilação com um sulfonato de alquil fluoroalquila

Country Status (13)

Country Link
US (1) US20160130280A1 (cg-RX-API-DMAC10.html)
EP (1) EP3010926B1 (cg-RX-API-DMAC10.html)
JP (1) JP6574173B2 (cg-RX-API-DMAC10.html)
KR (1) KR20160021243A (cg-RX-API-DMAC10.html)
CN (2) CN105324386B (cg-RX-API-DMAC10.html)
AU (1) AU2014282831B2 (cg-RX-API-DMAC10.html)
BR (1) BR112015029521A2 (cg-RX-API-DMAC10.html)
CA (1) CA2911104A1 (cg-RX-API-DMAC10.html)
HK (1) HK1219727A1 (cg-RX-API-DMAC10.html)
IL (1) IL242413B (cg-RX-API-DMAC10.html)
MX (1) MX2015017536A (cg-RX-API-DMAC10.html)
RU (1) RU2691728C2 (cg-RX-API-DMAC10.html)
WO (1) WO2014203185A1 (cg-RX-API-DMAC10.html)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104592254B (zh) * 2015-02-08 2016-07-13 福建省微生物研究所 依维莫司的合成方法
CN104876944B (zh) * 2015-05-13 2017-11-10 普济生物科技(台州)有限公司 一种依维莫司的制备方法
EP3109250A1 (en) * 2015-06-23 2016-12-28 Synbias Pharma AG Method for the synthesis of rapamycin derivatives
CN108047265A (zh) * 2017-11-24 2018-05-18 成都海创药业有限公司 一种依维莫司中间体的制备纯化方法
RU2716714C1 (ru) * 2019-08-26 2020-03-16 Закрытое Акционерное Общество "Биокад" Новый способ получения эверолимуса
CZ308817B6 (cs) * 2019-09-12 2021-06-09 Ratiochem, s.r.o. Způsob výroby Everolimu
JP2023028473A (ja) * 2021-08-19 2023-03-03 日本マイクロバイオファーマ株式会社 エベロリムスの製造方法
CN116082363B (zh) * 2023-02-16 2025-11-21 西安交通大学 一种雷帕霉素40-位羟基的烷基化合成方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9221220D0 (en) * 1992-10-09 1992-11-25 Sandoz Ag Organic componds
DE69624921T2 (de) * 1995-06-09 2003-09-11 Novartis Ag, Basel Rapamycinderivate
CN1235608A (zh) * 1996-09-09 1999-11-17 美国家用产品公司 烷基化的雷帕霉素衍生物
JP4716280B2 (ja) * 2004-03-01 2011-07-06 テルモ株式会社 O−アルキル化ラパマイシン誘導体の製造法
EP1571151B1 (en) 2004-03-01 2008-12-24 Terumo Kabushiki Kaisha Process for production of O-alkylated rapamycin derivatives
ES2296516B1 (es) 2006-04-27 2009-04-01 Laboratorios Almirall S.A. Derivados de 4-(2-amino-1-hidroxietil)fenol como agonistas del receptor beta2 adrenergico.
TW200948361A (en) * 2008-05-26 2009-12-01 Chunghwa Chemical Synthesis & Biotech Co Ltd Method for synthesizing Biolimus A9 and the like and method for improving stability of the same
CN102127092B (zh) * 2010-01-18 2013-04-17 东南大学 依维莫斯的制备
ES2753529T3 (es) * 2010-11-19 2020-04-13 Biocon Ltd Procesos para la preparación de everolimús y productos intermedios del mismo
EP2670758B1 (en) * 2011-02-04 2022-09-28 Synthon BV Process for making trisubstituted silyloxyethyl triflates

Also Published As

Publication number Publication date
CN109651396A (zh) 2019-04-19
KR20160021243A (ko) 2016-02-24
CN105324386B (zh) 2019-02-19
WO2014203185A1 (en) 2014-12-24
CN109651396B (zh) 2021-09-14
IL242413B (en) 2018-04-30
HK1219727A1 (zh) 2017-04-13
EP3010926B1 (en) 2019-11-20
US20160130280A1 (en) 2016-05-12
AU2014282831B2 (en) 2016-12-01
EP3010926A1 (en) 2016-04-27
CA2911104A1 (en) 2014-12-24
JP6574173B2 (ja) 2019-09-11
MX2015017536A (es) 2016-04-26
CN105324386A (zh) 2016-02-10
RU2015156316A (ru) 2017-07-25
RU2691728C2 (ru) 2019-06-18
AU2014282831A1 (en) 2015-11-12
JP2016523246A (ja) 2016-08-08

Similar Documents

Publication Publication Date Title
MX2015017536A (es) Alquilacion con un alquil sulfonato de fluoroalquilo.
BR112018075284A2 (pt) derivados de piperidinila substituída por (hetero)arila, processo para sua preparação e composições farmacêuticas contendo-os
BR112014030365A2 (pt) síntese de composto antiviral
CL2016000382A1 (es) Procesos para preparar compuestos antivirales
BR112013017510A2 (pt) misturas corantes dispersas, sua preparação e uso
BR112018075433A2 (pt) derivados de piperidinila, processo para sua preparação e composições farmacêuticas contendo-os
BR112015004113A2 (pt) 6-aminoácido heteroarila diidropirimidinas para o tratamento e profilaxia da infecção pelo vírus da hepatite b
BR112012033465A2 (pt) método para preparar um composto
BR112015007295A2 (pt) processo para a preparação de compostos; compostos; e uso dos mesmos
ECSP13012519A (es) Compuestos sustituidos de benzamida
DOP2010000089A (es) Derivados de quinazolinadiona, su preparacion y sus aplicaciones terapeuticas
AR088879A1 (es) Composicion fluoroquimica y su uso
BR112018073490A2 (pt) 6.7.beta-epóxidos esteroides como intermediários químicos
BRPI0900983A2 (pt) compostos de diometina, processo para sua preparação e composições farmacêuticas contendo os mesmos
BR112012024792A2 (pt) processo de preparo de derivados de sulfonamido-benzofurano
BR112017005218A2 (pt) mistura de compostos, processo para fabricar uma mistura, formulação aquosa, e, uso de misturas de compostos.
BR112012031314A2 (pt) "processo de preparo de compostos esteramidas"
WO2014054058A3 (en) Novel compounds, their synthesis and their uses
BR112013016637A2 (pt) processo para a preparação de derivados de 3-alquil-sulfinilbenzoíla
BR112014014604A2 (pt) processo para a preparação de um composto, e, composto isolado e purificado
BR112015018222A2 (pt) método para produzir um composto tricíclico, e composto tricíclico que pode ser produzido pelo referido método de produção
BR112014009390A2 (pt) corantes ácidos de trisazóicos
CL2019000017A1 (es) Procesos novedosos para la preparación de estimuladores de guanilato ciclasa soluble.
BR112017013266A2 (pt) processo para preparação de um composto, composto, e, usos de um composto e de uma dispersão.
BR112012013005A2 (pt) compostos químicos e seu uso como pesticidas.

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 5A ANUIDADE.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2519 DE 16-04-2019 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.

B350 Update of information on the portal [chapter 15.35 patent gazette]